Previous 10 | Next 10 |
NASHVILLE, Tenn. , Oct. 15, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a U.S. specialty pharmaceutical company announces a new publication in Infectious Diseases and Therapy , showing numerically superior cure rates of telavancin compared to vancomycin within ...
NASHVILLE, Tenn. , Sept. 24, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced FDA Orphan Drug Grant funding for a new Phase II clinical program. The Company has initiated the clinical development of ifetroban for...
Cumberland Pharmaceuticals Inc. (CPIX) Q2 2019 Earnings Conference Call August 14, 2019, 04:30 PM ET Company Participants Erin Gull - Corporate Relations A.J. Kazimi - CEO Marty Cearnal - Chief Commercial Officer Michael Bonner - CFO Conference Call Participants Presenta...
Cumberland Pharmaceuticals (NASDAQ: CPIX ): Q2 Non-GAAP EPS of $0.10 beats by $0.03 ; GAAP EPS of -$0.04 beats by $0.04 . More news on: Cumberland Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
NASHVILLE, Tenn. , Aug. 14, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a specialty pharmaceutical company focused on hospital acute care and gastroenterology today announced second quarter 2019 financial results with net revenues of $11.6 million , up ...
NASHVILLE, Tenn. , Aug. 7, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release second quarter 2019 financial results after the market closes on Wednesday, August 14 , 2019. A conference call and live Internet webcast will ...
Deals and Financings MGI Tech Company, a Shenzhen maker of gene sequencing machines, announced it closed its first funding round with more than $200 million. MGI is a subsidiary of BGI, China's largest sequencing services provider. Founded in 2016, MGI is dedicated to offering a China altern...
Gainers : PDS Biotechnology (NASDAQ: PDSB ) +35% . Navios Maritime Holdings (NYSE: NM ) +26% . Cellectar Biosciences (NASDAQ: CLRB ) +21% . Nordic American Tankers (NYSE: NAT ) +14% . Ocean Bio-Chem (NASDAQ: OBCI ) +13% . Genetic Technologies (NASDAQ: GENE ) +13% . Amdocs (NASDAQ: DO...
NASHVILLE, Tenn. , May 15, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a specialty pharmaceutical company, today announced it has entered into an exclusive agreement with China's Winhealth Pharma Group for the licensing rights of Acetadote ® ( ac...
Cumberland Pharmaceuticals Inc. (CPIX) Q1 2019 Results Earnings Conference Call May 14, 2019, 04:30 PM ET Company Participants Erin Smith - Corporate Relations A.J. Kazimi - CEO Marty Cearnal - Chief Commercial Officer Michael Bonner - CFO Conference Call Participants And...
News, Short Squeeze, Breakout and More Instantly...
Cumberland Pharmaceuticals Inc. Company Name:
CPIX Stock Symbol:
NASDAQ Market:
Cumberland Pharmaceuticals Inc. Website:
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS PR Newswire NASHVILLE, Tenn. , April 30, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release ...
NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS PR Newswire Growing data shows intravenous ibuprofen is safe and effective for the treatment of pain and fever in adults, children and infants NASHVILLE, Tenn. , Ap...
Cumberland Pharmaceuticals Reports Annual 2023 Financial Results PR Newswire 2023 highlights include expanded FDA approval and new study publications NASHVILLE, Tenn. , March 5, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a sp...